Home-Health Denial Escalation
A clinical analysis for home-health prior-authorization, admission, episode, or visit-related medical-necessity denials. It addresses the need for skilled nursing or therapy, homebound status when applicable, frequency and duration, measurable goals, caregiver limitations, safety risks, and the feasibility of alternatives.
A bounded clinical support service.
A clinical analysis for home-health prior-authorization, admission, episode, or visit-related medical-necessity denials. It addresses the need for skilled nursing or therapy, homebound status when applicable, frequency and duration, measurable goals, caregiver limitations, safety risks, and the feasibility of alternatives.
Scope boundary. The client retains filing, portal work, deadlines, signatures, coding, legal strategy, patient care, and any required U.S.-licensed or specialty opinion unless a separate approved scope expressly says otherwise.
The decision problem this service addresses.
Home-health cases can fail when the record describes diagnoses and tasks but does not show why the work requires a skilled professional, why the frequency is reasonable, or how function and homebound status satisfy the applicable pathway. Coverage and documentation requirements vary by payer and benefit; a generic Medicare statement should not be reused without confirming applicability.
What the review must resolve.
Skilled service
Why does the intervention require professional nursing or therapy judgment?
Homebound or setting element
When applicable, what documented limitation makes leaving home difficult or medically contraindicated?
Frequency and duration
Why are the requested visits and episode length reasonable?
Function and safety
What impairment or risk affects self-management and alternatives?
Caregiver reality
What support is actually available, trained, willing, and capable?
Alternative pathway
Could outpatient care, self-management, or a lower frequency meet the documented need?
The clinical work product.
- Episode and function chronology.
- Evidence map for skilled need, homebound status when relevant, frequency, goals, and risk.
- Direct response to the payer reason, plus missing documentation and adverse facts.
- Handoff-ready clinical reasoning; no order, certification, or plan-of-care signature.
What the client must supply.
Turnaround begins after the agreed record is complete and usable. New records, a different denial rationale, another review period, or a second independent issue can change scope.
- Denial or authorization notice and requested episode
- Treating-clinician orders and plan-of-care documents
- Home-health nursing, therapy, reassessment, progress, and discharge records
- Functional, homebound, caregiver, safety, and environment documentation
- Payer policy and authorization history
How buyers handle the work today.
- Agency authorization and QA staff.
- Treating clinician plan-of-care documentation.
- Outsourced PA/RCM processing.
- Physician-advisor or denial vendor review.
- Legal/compliance review when the dispute is contractual or regulatory rather than clinical.
The intended role in the workflow.
It targets selected clinically ambiguous denials rather than commoditized authorization processing. It is therefore more expensive than routine administrative PA outsourcing and should not be sold for every case.
What the service is designed to prevent.
These are not proof that a denial is wrong. They are ways a potentially supportable case becomes unfocused, overstated, or routed to the wrong capability.
- Calling a task skilled without explaining the judgment or risk involved
- Using diagnosis alone to prove homebound status or visit frequency
- Relying on caregiver absence without documenting skilled need
- Repeating unchanged goals without progress or plan revision
- Ignoring whether outpatient or lower-frequency care is feasible
Market comparison and current Clinovian scope.
Routine outsourced prior-authorization vendors may advertise low single-digit per-authorization rates at scale, while clinical denial review remains quote-based. These are different scopes. (Staffingly) No reliable public clinician-review fee was found.
Clinovian scope and pricing: Quote required under the current combined post-acute pricing. Normal public turnaround: 5–7 business days after complete usable inputs.
Final scope, fixed fee, and turnaround are confirmed before records are transferred; the Engagements & Pricing page remains the public pricing framework.
When to choose it—and when not to.
Choose it when the agency has a complete clinical record but needs clearer skilled-need and functional reasoning. Do not choose it when missing signatures, orders, face-to-face documentation, eligibility, or benefit rules—not the clinical argument—control the outcome.
Send the decision, not the whole account. Fit is confirmed before records.
Provide the denial or request type, payer or plan, review stage, record size, and client-controlled deadline. No PHI is required for the initial scope review.